92 A phase I, pharmacological and biological study of Sarasar® (Ionafarnib, SCH 66336), cisplatin and gemcitabine in patients with advanced solid tumors
L. Gore, M. Basche, S.N. Holden, C. O'Bryant, M.K. Schultz, S. Grolnic, M. Morrow, S.G. EckhardtVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80100-9
File:
PDF, 295 KB
english, 2004